Name: Parvez jamal Age/Gender: 72 Year(s) 0 Months(s) 0 Day(s)/Male
0000006893592
Referred By: Self Client Name: Paras Medico Healthcare
Collection Date: 20-01-2024 14:02:00 Report Release Date: 20-01-2024 20:40:36
No. Investigation Observed Value Unit Biological Reference Interval
Lipid Profile
1 Total Cholesterol 151.0 mg/dL Desirable: <200;
Serum, Method: Cholesterol Borderline high = 200-239;
oxidase,esterase,peroxidase High: > 240
2 Triglycerides 179.9 mg/dL Desirable: <150
Serum, Method: Enzymatic, end point GPO-POD Borderline High: 150 - 199
High: > 200 - 499
3 HDL-Cholesterol 55.9 mg/dL 30 - 60
Serum, Method: Enzymatic Immunoinhibition
4 LDL- Cholesterol 77.11 mg/dL Optimal: <100;
Serum, Method: Enzymatic selective Protection Near Optimal: 100-129;
Borderline High: 130-159;
High: 160-189;
Very high: >190
5 Cholesterol/HDL ratio 2.70 Optimal: <3.5
Serum, Method: Calculated Near Optimal: 3.5 - 5.0
High >5.0
6 VLDL Cholesterol 35.98 mg/dL 6 - 40
Serum, Method: Calculated
7 Non HDL Cholesterol 95.10 mg/dl Desirable: <130
Serum, Method: Calculated Borderline high: 130-159
High : 160-189
Very High :>190
8 LDL /HDL ratio 1.38 Optimal: <2.5
Serum, Method: Calculated Near Optimal: 2.5-3.5
High >3.5
Interpretation
1.Triglycerides: When triglycerides are very high greater than 1000 mg/dL, there is a risk of developing pancreatitis in children
and adults. Triglycerides change dramatically in response to meals, increasing as much as 5 to 10 times higher than fasting
levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting
triglycerides measured on different days are not considered to be abnormal.
2. HDL-Cholesterol: HDL- C is considered to be beneficial, the so-called "good" cholesterol, because it removes excess
cholesterol from tissues and carries it to the liver for disposal. If HDL-C is less than 40 mg/dL for men and less than 50 mg/dL
for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The
NCEP guidelines suggest that an HDL cholesterol value greater than 60 mg/dL is protective and should be treated as a negative
risk factor.
3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120
mg/dL is acceptable. Values between 120-159 mg/dL are considered Borderline high. Values greater than 160 mg/dL are
considered high. Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people
with hyperthyroidism, infection, inflammation, or cirrhosis.
CRM No :6893592
Sample Recd. Time: 20-01-2024 18:12
Report Time: 20-01-2024 20:40 Authorized Signatory
Patient Name: Parvez jamal DR. MALAY BAJPAI
Patient ID: 6893592 MD(Pathology)
Scan For Report Scan To Verify
Page 1 of 2
Name: Parvez jamal Age/Gender: 72 Year(s) 0 Months(s) 0 Day(s)/Male
0000006893592
Referred By: Self Client Name: Paras Medico Healthcare
Collection Date: 20-01-2024 14:02:00 Report Release Date: 20-01-2024 20:40:36
No. Investigation Observed Value Unit Biological Reference Interval
1 PSA -Total 0.46 ng/ml 0-4
Serum, Method: CLIA
Interpretation
Prostate cancer is leading cancer in older men. Therefore, early detection is important and Prostate specific antigen (PSA) is
widely used for this purpose. It is considered as one of the most promising tumor marker available. The absolute value of serum
PSA is useful for determining the extent of prostate cancer and assessing the response to therapy. Its use as a screening method
to detect prostate cancer is limited as it is prostate tissue specific and not a prostate cancer specific marker.
PSA exists in three forms–
1) PSA enveloped by protease inhibitor Alpha-2-macroglobulin- This form lacks immunoreactivity.
2) PSA enveloped by protease inhibitor Alpha-1-antichymotrypsin (ACT)
3) PSA not complexed to any protease inhibitor- This is called ‘Free PSA’
The ACT bound PSA & Free PSA are collectively called ‘Total PSA’
Free PSA alone has not been shown to be effective in patient management. Both Total and Free PSA concentrations should be
determined on the same serum specimen to calculate the percentage of Free PSA.
End Of Report
CRM No :6893592
Sample Recd. Time: 20-01-2024 18:12
Report Time: 20-01-2024 20:40 Authorized Signatory
Patient Name: Parvez jamal DR. MALAY BAJPAI
Patient ID: 6893592 MD(Pathology)
Scan For Report Scan To Verify
Page 2 of 2
QUALITY POLICY
GENERAL DIAGNOSTICS INTERNATIONAL (P) Ltd. maintains the highest standards of quality control in all aspects
of laboratory work. The purpose of our laboratory’s Quality Management System is to ensure that:
Principles of all accreditations, including that of NABL - ISO1518:2012 (National Accreditation Board of Laboratories) are adhered
for each test in the scope of the accreditation, and beyond.
Test methods, processes and control mechanisms are timely updated and fully validated to ensure the accuracy and
reliability of our test results.
The objectives of our Quality Control system are:
Use Bar-Coded operations to enable full traceability throughout the sample flow process and to ensure sample handling
procedures and environmental conditions are managed well and there is no or minimal affect on the results.
Continually improve the practices of our clients, franchise partners, associate doctors, clinics and hospitals and monitor their
training needs. Be proactive in identifying gaps in the processes being followed. Guide them to ensure that the patients are
served in the best possible way.
Report the results with accuracy and clarity in a timely manner. Do a root cause analysis whenever there is a deviation against
protocols and find solutions to the identified causes.
Ensure a continual enhancement, implementation and maintenance of the quality system and seek improvement in the
effectiveness of the quality system from experts at regular intervals.
Meet and exceed expectations with respect to turn-around time, sample collection hygiene & reliability of service.
Ensure that each test is performed by qualified and trained staff. Provide opportunities to the staff so that they can increase
their knowledge and use the same for self and organizational betterment.
Ensure that the equipment used are best in class, properly maintained and calibrated and where possible, measurements are
traceable to recognized standards. Also explore methods which may lead to improvement in equipment performance and
methodologies used for conducting tests.
Enable technology upgrades to achieve higher accuracy and reduced complexities.
Use internal audits and other checks to ensure the quality system complies with requirements; ensure problems are
investigated promptly, root cause(s) established and effective action taken to prevent a recurrence.
Have a smooth communication mechanism to ensure information is made available as rapidly as possible to those who need
it, both internal and external to the organization.
Monitor, help and support our franchise and service partners to be sensitive on all aspects of service delivery and to ensure
quality standards are followed with no exceptions.
CONDITIONS of REPORTING
01. It is presumed that the specimen accompanying the TRF (Test Requisition Form where 07. For certain category of tests, the report may carry a “PRELIMINARY” status implying
the details of patient are recorded) is of the same patient whose details are there in the that the results are yet to be reported for one (or more) tests. For example, in the case
TRF. with certain microbiology tests, a “FINAL” culture, identification or drug susceptibility
02. A test requested might not be performed due to the following reasons(s): result might be pending. In such case, the status “RESULT PENDING” will be mentioned
2.1 Insufficient quantity of specimen required to conduct the test. on report. The same shall be replaced by the test results whenever it is ready.
2.2 Poor quality of the Specimen not meeting the quality criteria 08. If the collection date or any other details was not stated in the Test Requisition Form,
(hemolysis of sample/clotted.) the same will not be printed on the report. In cases where the missing information is
2.3 Incorrect specimen type as required to conduct a test. mandatory for report generation or meeting accreditation guidelines, the sample
03. Test(s) may be patly or fully cancelled due to incorrect test code, incorrect name of the shall not be processed at all.
test or incorrect type of specimen. A communication shall be made and it is expected 09. Tests parameters excluded from the “scope” of NABL accreditation shall be marked
that a fresh specimen will be sent to laboratory for analysis of same parameter(s). by asterisks.
04. The results of laboratory investigation are dependent on the quality of the specimen as 10. In case you are not the intended recipient of the report, please immediately inform
well as the assay procedures/technologies used. All samples collected for tests are the same to the issuing entity. Any use, disclosure, copy or distribution of any
required to be prepared, stored, labeled and brought to processing laboratory as per the contents of such report, is unlawful and is strictly prohibited.
prescribed guidelines of GENERAL DIAGNOSTICS. 11. Some test may be referred to other laboratories to provide a wider test menu to the
05. GENERAL DIAGNOSTICS laboratory cannot be held liable for incorrect results of a sample patients. The details of the laboratory where the sample was referred to, can be
which deviated from the guidelines issued. obtained from Customer Care department.
06. There can be several factors like sample’s unintended exposure to heat or travel through 12. Claims of comparing results against that from a different laboratory shall be looked
rough terrain which affect the quality of test results. Therefore a 2% chance of error/ into only if it was the same sample which was split and sent in same conditions to all
deviation in results is a possibility. laboratories and processed on the same technology.
इस का मूल आधार है “बेटी”
माता पता ही नह , देश का स ान है “बेटी” बेटी बचाओ बे पढ़ाओ
GENERAL DIAGNOSTICS INTERNATIONAL (P) LTD., Plot - 06, Sector-24, Turbhe, Navi Mumbai, Maharashtra, India - 400 705.
022 - 4045 0000 / +91 98717 15111
[email protected] www.gd-lab.com
